Clinical Focus Target brain cancer surgery market with Tumor Paint technology to assist pediatric neurosurgeons, highlighting a clear use case for intraoperative imaging and tumor delineation.

Strategic Acquisition Leverage past acquisition of Teal Light Surgical and the Canvas Imaging System to expand capabilities in surgical visualization and real-time imaging, offering potential integration with existing hospital procurement channels.

R&D Funding Capitalize on prior Series A funding and ongoing immuno-oncology development to position Blaze for partnerships or licensing deals around tumor visualization agents and companion diagnostics.

Commercial Readiness Empresa operates with a modest employee base and revenue in the low-millions; opportunities exist to scale via OEM, distributor partnerships, or contract manufacturing for imaging systems and related consumables.

Market Positioning Differentiate as a pediatric-focused oncology tech company combining tumor painting agents with imaging platforms, enabling conversations with hospital systems, surgeons, and cancer centers seeking precision resection tools.